85
Views
9
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Prioritization of cancer antigens: keeping the target in sight

, &
Pages 1657-1661 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Petr G Lokhov & Elena E Balashova. (2015) Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC). Human Vaccines & Immunotherapeutics 11:3, pages 689-698.
Read now
Petr G. Lokhov & Elena E. Balashova. (2013) Universal cancer vaccine. Human Vaccines & Immunotherapeutics 9:7, pages 1549-1552.
Read now

Articles from other publishers (7)

Irina Alekseenko, Alexey Kuzmich, Liya Kondratyeva, Sofia Kondratieva, Victor Pleshkan & Eugene Sverdlov. (2021) Step-by-Step Immune Activation for Suicide Gene Therapy Reinforcement. International Journal of Molecular Sciences 22:17, pages 9376.
Crossref
Ki-Cheol Han, Daechan Park, Shinyeong Ju, Young Eun Lee, Sun-Hee Heo, Young-Ae Kim, Ji Eun Lee, Yuna Lee, Kyong Hwa Park, Se-Ho Park, Hee Jin Lee, Cheolju Lee & Mihue Jang. (2020) Streamlined selection of cancer antigens for vaccine development through integrative multi-omics and high-content cell imaging. Scientific Reports 10:1.
Crossref
Petr G. Lokhov & Elena E. Balashova. (2016) Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines. Journal of Immunology Research 2016, pages 1-7.
Crossref
K Sideras, S J Bots, K Biermann, D Sprengers, W G Polak, J N M IJzermans, R A de Man, Q Pan, S Sleijfer, M J Bruno & J Kwekkeboom. (2015) Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area. British Journal of Cancer 112:12, pages 1911-1920.
Crossref
Teresa Ramirez-Montagut. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies 365 388 .
David Kosoff, Timothy Krueger & Joshua M Lang. (2013) Targeting epigenetic mechanisms for clinical translation: enhancing the efficacy of tumor immunotherapies. Immunotherapy 5:11, pages 1243-1254.
Crossref
Luis E. Fernandez, Mariano R. Gabri, Marcelo D. Guthmann, Roberto E. Gomez, Silvia Gold, Leonardo Fainboim, Daniel E. Gomez & Daniel F. Alonso. (2010) NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines. Clinical and Developmental Immunology 2010, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.